|1.||Koren, Gideon: 4 articles (11/2013 - 03/2002)|
|2.||Centers for Disease Control and Prevention (CDC): 3 articles (07/2013 - 03/2006)|
|3.||Hambleton, Sophie: 2 articles (09/2011 - 06/2011)|
|4.||Bate, Jessica: 2 articles (09/2011 - 06/2011)|
|5.||Oberste, M Steven: 1 article (07/2015)|
|6.||Grunewald, Stacey: 1 article (07/2015)|
|7.||Nix, W Allan: 1 article (07/2015)|
|8.||Buttery, Vicki W: 1 article (07/2015)|
|9.||Kenyon, Cynthia: 1 article (07/2015)|
|10.||Bapat, Priya: 1 article (11/2013)|
11/01/2013 - "The following review critically examines the role of VariZIG in post-exposure prophylaxis of varicella during pregnancy. "
03/30/2012 - "FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella."
10/01/2011 - "Patients who had been given VZIG and developed varicella on follow-up had a mean antibody level before VZIG of 28 mIU/ml and 62 mIU/ml, by LIAISON and TRFIA, respectively. "
02/08/2011 - "Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin."
12/01/2009 - "It has been suggested that it would be more cost-effective to screen antenatally with post-partum vaccination, which occurs in the US, than the current policy of checking immune status post varicella exposure, with VZIG administration where necessary. "
08/01/1998 - "If exposure occurs, VZIG should be administered within 96 hours in an attempt to prevent maternal infection. "
04/01/1983 - "VZV infection occurred in 49 (60.4%) of 81 recipients of VZIG and in 57 (68.6%) of 83 recipients of ZIG. "
02/01/2001 - "As both VZIG and hospitalization are costly, prevention of varicella infection by vaccination could potentially result in significant cost savings in addition to decreasing morbidity and mortality. "
06/01/1996 - "From a cost-effectiveness/cost-benefit standpoint, management based on immune testing is preferable to universal varicella-zoster immune globulin administration when caring for the varicella-exposed gravida with a negative or indeterminate infection history."
08/01/1992 - "Two children died of complications of varicella infection, including 1 child who received VZIG on the day of exposure to varicella. "
09/01/1992 - "We concluded that Uman-VZIG, both by intralesional and intramuscular administration, is effective and safe in Herpes Zoster treatment."
06/01/2001 - "VZV immune globulin (VZIG) prevents or modifies clinical illness in persons who have been exposed to varicella or zoster."
04/01/1989 - "Screening for varicella-zoster immunity and the use of varicella zoster immune globulin in pregnancy."
02/01/1989 - "Physicians can reduce morbidity from these conditions by advising nonimmune pregnant women to avoid exposure to chickenpox and herpes zoster and, when indicated, by promptly administering varicella-zoster immune globulin. "
08/01/1984 - "Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin."
01/01/1996 - "The objective of this study was to compare the cost-effectiveness of 3 strategies of serologic enzyme-linked immunosorbent assay (ELISA) testing and post-exposure varicella zoster immune globulin (VZIG) prophylaxis for the prevention of maternal varicella pneumonia during pregnancy in patients with negative or uncertain histories of varicella infection. "
07/31/2015 - "Identifying the cause of the rash was important to determine whether administration of varicella zoster immune globulin was indicated to prevent neonatal varicella. "
04/01/1990 - "Appropriate management includes tocolysis, unless contraindicated, and varicella-zoster immune globulin (VZIG) administered to the mother within 72 hours of delivery, or to the neonate when the mother's rash appears within 48 hours after delivery. "
07/01/2000 - "Further, with varicella zoster immunoglobulin (VZIG) prophylaxis and acyclovir treatment soon after rash onset, the course in immunocompromised individuals is also usually benign. "
|1.||varicella-zoster immune globulin (VZIG)
|4.||Chickenpox Vaccine (Vaccine, Varicella)
|5.||Immunoglobulin G (IgG)
|6.||Intravenous Immunoglobulins (IVIG)
|7.||Complement System Proteins (Complement)
|2.||Transplantation (Transplant Recipients)